Position in AQST
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$895,714
+$702,160 QoQ
Shares Held
215,316
+618.6% QoQ
Ownership
0.172%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#48
of 185 holders
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AQST Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Lido Advisors, LLC holds $12,595,878 across 15 Drug Manufacturers - Specialty & Generic names. AQST ranks #3 (7.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LNTH |
Lantheus Holdings, Inc.
|
49,202 | $5,458,469 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
1,812 | $981,795 | |
| 3 | AQST |
Aquestive Therapeutics, Inc.
This page
|
215,316 | $895,714 | |
| 4 | HROW |
Harrow, Inc.
|
16,489 | $700,287 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
20,469 | $693,489 | |
| 6 | VTRS |
Viatris Inc
|
40,486 | $642,917 | |
| 7 | INDV |
Indivior Pharmaceuticals, Inc.
|
13,628 | $559,156 | |
| 8 | ZTS |
Zoetis Inc.
|
7,722 | $554,901 |
All Filings in AQST
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $895,714 | 215,316 | Shares | Sole | 2026-08-07 | |
| 2025-12-31 | $193,554 | 29,962 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $167,487 | 29,962 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||